RGEN

#1068
Repligen Corp
131.9300 USD
+0.69%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
131.9300
131.9300
Range Annuel
109.6600
175.5700
Changement quotidien
+0.69%
Changement Mensuel
+12.61%
Evolution sur 6 mois
-20.38%
Changement Annuel
-20.38%
Clôture Précédente
131.0300
Open
131.9300
Bid
Ask
Low
131.9300
High
131.9300
Volume
146
Open full chart

Financials

Overview Relevé Statistics
Quarterly Annual
  • Market Capitalization 7.4318 B
  • Employee 2 000
  • Founded 1981
  • CEO Tony J. Hunt
  • Website www.repligen.com
  • Headquarter Delaware, United States
  • FIGI BBG000BS48J3
  • Industry Instruments et Fournitures Médicales
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
190.53
Price to sales ratio
0.01

Repligen Corporation

Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs. The company is based in Waltham, Massachusetts, and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of 2025, Repligen employs over 1,900 employees globally and serves primarily biopharmaceutical drug developers and contract development and manufacturing organizations worldwide.

Nouvelles